Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to ...

After three years of VP250, 83.5% of participants reached an eliciting dose (ED) of ≥1000 mg, an increase from 64.2% at month ...

Turmeric soap may benefit your skin in several ways, like promoting an even skin tone. Learn how you might use it in your ...

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment ...

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has been given a consensus recommendation of “Buy” by the seven analysts that are presently covering the firm, Marketbeat Ratings reports.

Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Mizuho from $19.00 to $20.00 in a research note released on Tuesday,Benzinga reports. They currently have an ...